Dublin, May 06, 2025 (GLOBE NEWSWIRE) -- The "Lab-on-a-Chip Market Size, Share & Trends Analysis Report By Product & Service (Reagents & Consumables), By Technology (Microfluidics Technology, Optical Technology), By Application (Clinical Diagnostics), By End Use, By Region, And Segment Forecasts, 2025 - 2030" report has been added to ResearchAndMarkets.com's offering.
The global lab-on-a-chip market size is expected to reach USD 11.45 billion by 2030 and is expected to grow at a CAGR of 9.76% from 2025 to 2030.
The market is driven by rising investments in healthcare R&D, integration of AI in diagnostics, and government initiatives supporting personalized medicine and decentralized testing.
The lab-on-a-chip market is experiencing significant growth due to advancements in microfluidics technology, which has improved the precision and efficiency of diagnostic processes. In addition, the integration of lab-on-a-chip devices in clinical and research laboratories has streamlined workflows, further reducing the time required for complex analyses. The demand for high-throughput screening in the pharmaceutical and biotechnology industries has also expanded the applications of lab-on-a-chip technology, enabling faster drug discovery and personalized treatment approaches.
Furthermore, the rising adoption of telemedicine and remote patient monitoring has increased the need for portable diagnostic solutions, which has placed lab-on-a-chip as an important component in decentralized healthcare systems.
The development of cost-effective manufacturing techniques, including 3D printing and nanofabrication, has enhanced the scalability of lab-on-a-chip production, making these devices more accessible. Moreover, increasing government funding and private investments in healthcare innovation have further accelerated research and commercialization of lab-on-a-chip technologies.
Key market players are adopting various strategies to enhance the effectiveness and reliability of Lab-on-a-Chip technologies by integrating advanced microfluidics, AI-driven analytics, and biomimetic systems. Companies are focusing on improving drug testing accuracy, organ-on-chip models, and point-of-care diagnostics to meet the growing demand for personalized medicine and decentralized healthcare.
In September 2024, Emulate, Inc. announced the launch of Chip-R1 Rigid Chip, designed to minimize drug absorption and enhance biological modeling. This innovation addresses the challenge of drug compound loss during in vitro testing, thereby improving the accuracy of pharmacokinetic and toxicological assessments.
Lab-on-a-Chip Market Report Highlights
- Based on product & service, reagents & consumables dominated the market due to their essential role in diagnostic procedures, ensuring high sensitivity and accuracy. The increasing demand for single-use cartridges and microfluidic reagents has further driven market growth.
- Based on technology, microfluidics technology held the largest revenue share in 2024 due to its ability to enable precise fluid handling at a microscale, improving diagnostic accuracy and efficiency.
- Based on application, clinical diagnostics held the largest revenue share in 2024 due to the increasing need for rapid, cost-effective, and accurate disease detection. The widespread use of Lab-on-a-Chip devices for infectious disease testing, cancer screening, and genetic an a has propelled market growth.
- Based on end use, hospitals, and diagnostic centers held the largest revenue share in 2024 due to their extensive use of lab-on-a-chip technology for diagnostic purposes.
- Based on region, North America dominated the market in 2024 due to the presence of numerous leading pharmaceutical and biotechnology companies, driving the demand for cutting-edge diagnostic and testing solutions.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 100 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value (USD) in 2024 | $6.61 Billion |
| Forecasted Market Value (USD) by 2030 | $11.45 Billion |
| Compound Annual Growth Rate | 9.7% |
| Regions Covered | Global |
Key Topics Covered:
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Lab-on-a-Chip Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing Demand for Point Of Care Diagnostics
3.2.1.2. Technological Advancements in Microfluidics and Miniaturization
3.2.1.3. Increasing Incidence of Chronic Diseases and Infectious Diseases
3.2.2. Market Restraint Analysis
3.2.2.1. High Development and Manufacturing Costs
3.2.2.2. Stringency In Regulatory Approval Processes
3.3. Industry Analysis Tools
Chapter 4. Lab-on-a-Chip Market: Product & Service Estimates & Trend Analysis
4.1. Product & Service Segment Dashboard
4.2. Global Lab-on-a-Chip Market Product & Service Movement Analysis
4.3. Global Lab-on-a-Chip Market Size & Trend Analysis, by Product & Service, 2018 to 2030 (USD Million)
4.4. Reagents & Consumables
4.5. Instruments
4.6. Software & Services
Chapter 5. Lab-on-a-Chip Market: Technology Estimates & Trend Analysis
5.1. Technology Segment Dashboard
5.2. Global Lab-on-a-Chip Market Technology Movement Analysis
5.3. Global Lab-on-a-Chip Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
5.4. Microfluidics Technology
5.5. Optical Technology
5.6. Electrochemical Technology
5.7. Others
Chapter 6. Lab-on-a-Chip Market: Application Estimates & Trend Analysis
6.1. Application Segment Dashboard
6.2. Global Lab-on-a-Chip Market Application Movement Analysis
6.3. Global Lab-on-a-Chip Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
6.4. Drug Discovery & Development
6.5. Clinical Diagnostics
6.6. Others
Chapter 7. Lab-on-a-Chip Market: End Use Estimates & Trend Analysis
7.1. End Use Segment Dashboard
7.2. Global Lab-on-a-Chip Market End Use Movement Analysis
7.3. Global Lab-on-a-Chip Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
7.4. Academic & Research Institutes
7.5. Hospitals & Diagnostic Centers
7.6. Pharmaceutical & Biotechnological Companies
7.7. Others
Chapter 8. Lab-on-a-Chip Market: Regional Estimates & Trend Analysis
8.1. Regional Market Share Analysis, 2024 & 2030
8.2. Regional Market Dashboard
8.3. Market Size & Forecasts and Trend Analysis, 2018 to 2030
Chapter 9. Competitive Landscape
- Thermo Fisher Scientific, Inc.
- Illumina, Inc.
- Danaher
- Merck KGaA
- Abbott Laboratories
- QIAGEN
- Agilent Technologies
- Standard BioTools
- Revvity, Inc.
- Bio-Rad Laboratories
For more information about this report visit https://www.researchandmarkets.com/r/ut0znl
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
